CD72 regulates the growth of KIT-mutated leukemia cell line Kasumi-1.

scientific article published on 04 October 2013

CD72 regulates the growth of KIT-mutated leukemia cell line Kasumi-1. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/SREP02861
P932PMC publication ID3980566
P698PubMed publication ID24713856
P5875ResearchGate publication ID261515907

P50authorMasahiro KawaharaQ66829145
P2093author name stringAtsushi Kumanogoh
Tatsuaki Tsuruyama
Hironori Haga
Chiyuki Ueshima
Masahiro Hirata
Tatsuki R Kataoka
Koki Moriyoshi
P2860cites workCD72 negatively regulates KIT-mediated responses in human mast cellsQ24297400
Gain-of-function mutations of c-kit in human gastrointestinal stromal tumorsQ28118852
Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signalingQ28140151
Involvement of CD100, a lymphocyte semaphorin, in the activation of the human immune system via CD72: implications for the regulation of immune and inflammatory responsesQ28189775
Stat4 suppresses the proliferation of connective tissue-type mast cells.Q53473580
Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemiasQ59511707
c-kit proto-oncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukaemiaQ59511748
Human Lyb-2 homolog CD72 is a marker for progenitor B-cell leukemiasQ67544291
Kit as a human oncogenic tyrosine kinaseQ28297098
The Kasumi-1 cell line: a t(8;21)-kit mutant model for acute myeloid leukemiaQ28300267
Identification of CD72 as a Lymphocyte Receptor for the Class IV Semaphorin CD100Q29036802
Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorderQ33784323
The CD100-CD72 interaction: a novel mechanism of immune regulationQ34460685
A SHPing tale: perspectives on the regulation of SHP-1 and SHP-2 tyrosine phosphatases by the C-terminal tailQ36220787
Integrated signalling pathways for mast-cell activationQ36392833
Pharmacological targeting of the KIT growth factor receptor: a therapeutic consideration for mast cell disordersQ36842503
Complementing mutations in core binding factor leukemias: from mouse models to clinical applicationsQ37208315
Immunotherapy prospects for acute myeloid leukaemiaQ37763280
Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit productQ38315689
CD72 down-modulates BCR-induced signal transduction and diminishes survival in primary mature B lymphocytesQ39133323
Casticin induces leukemic cell death through apoptosis and mitotic catastropheQ39896019
Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cellsQ40077017
Novel role of HDAC inhibitors in AML1/ETO AML cells: activation of apoptosis and phagocytosis through induction of annexin A1.Q40140332
The c-Jun-N-terminal-Kinase inhibitor SP600125 enhances the butyrate derivative D1-induced apoptosis via caspase 8 activation in Kasumi 1 t(8;21) acute myeloid leukaemia cellsQ40217567
Eriocalyxin B induces apoptosis of t(8;21) leukemia cells through NF-kappaB and MAPK signaling pathways and triggers degradation of AML1-ETO oncoprotein in a caspase-3-dependent manner.Q40266774
STI 571 inhibition effect on KITAsn822Lys-mediated signal transduction cascadeQ40418498
KIT exon 8 mutations associated with core-binding factor (CBF)-acute myeloid leukemia (AML) cause hyperactivation of the receptor in response to stem cell factor.Q40477263
CD72 stimulation modulates anti-IgM induced apoptotic signaling through the pathway of NF-kappaB, c-Myc and p27(Kip1).Q40597201
17-Allylamino-17-demethoxygeldanamycin (17-AAG) is effective in down-regulating mutated, constitutively activated KIT protein in human mast cellsQ40627348
Amplification of a novel c-Kit activating mutation Asn(822)-Lys in the Kasumi-1 cell line: a t(8;21)-Kit mutant model for acute myeloid leukemiaQ40719234
The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutationsQ40748765
Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2.Q40869447
The B-cell transmembrane protein CD72 binds to and is an in vivo substrate of the protein tyrosine phosphatase SHP-1.Q41008340
The B cell surface protein CD72 recruits the tyrosine phosphatase SHP-1 upon tyrosine phosphorylation.Q41042524
Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation.Q41685189
Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kitQ44539087
CD72, a coreceptor with both positive and negative effects on B lymphocyte development and functionQ46208076
Familial gastrointestinal stromal tumours with germline mutation of the KIT geneQ47714133
P275copyright licenseCreative Commons Attribution 3.0 UnportedQ14947546
P6216copyright statuscopyrightedQ50423863
P407language of work or nameEnglishQ1860
P921main subjectleukemiaQ29496
cell lineQ21014462
P304page(s)2861
P577publication date2013-10-04
P1433published inScientific ReportsQ2261792
P1476titleCD72 regulates the growth of KIT-mutated leukemia cell line Kasumi-1.
P478volume3

Reverse relations

cites work (P2860)
Q36489379Human Head and Neck Squamous Cell Carcinoma-Associated Semaphorin 4D Induces Expansion of Myeloid-Derived Suppressor Cells
Q38778743Implication of protein tyrosine phosphatase SHP-1 in cancer-related signaling pathways.
Q41043876Killer cell immunoglobulin-like receptor 2DL4 is expressed in and suppresses the cell growth of Langerhans cell histiocytosis
Q64260508Semaphorins and Their Receptors in Hematological Malignancies
Q55405777The Role of Semaphorin 4D in Bone Remodeling and Cancer Metastasis.

Search more.